SYRE

SPYRE THERAPEUTICS INC

SYRE·00773J202·US·Common Stock·Healthcare - Biotechnology-Activist

SYRE (SPYRE THERAPEUTICS INC) is held by 143 institutional investors as of Q2 2026. Largest holders: FMR LLC ($1.2B), BlackRock, Inc. ($577.7M), RTW INVESTMENTS, LP ($377.5M). Net institutional sentiment: Bullish.

143
Holders
(11 Elite)
$5.8B
Total Value
80% (150)
Consensus
120 buying - 30 selling
13F: Insider & Congress: Updated regularly
SYRE

Smart Money Verdict

View all
Loading verdict
Held by 143 funds
11 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Aug 10, 2026 · Activists Aug 14, 2026 · Congress none

ActivistPAPerceptive Advisors LLC4.9%Aug 14, 2026
ActivistRTW Investments, LPRTW Investments, LP4.8%Aug 14, 2026
InsiderAWAlbers Jeffrey W.Sell $1.0MAug 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
13M(+10.6%)$1.2B0.1%+193.22%
35
Increased
6.5M(+17.9%)$577.7M0.0%+164.42%
37
Increased
4.3M(+1.9%)$377.5M3.2%+265.94%
58
Increased
3.4M(+12.8%)$306.2M0.0%+98.17%
35
Increased
3.1M(+17.3%)$271.4M0.0%+147.01%
36
Increased
2.8M(+0.3%)$248.5M1.4%+282.93%
48
Increased
2.6M(+48.9%)$239.3M0.0%+89.06%
42
Increased
2.3M(+298.2%)$206.9M0.0%+18.04%
49
Increased
2.3M(+247.4%)$205.6M0.0%+23.37%
49
Increased
1.8M(+44.8%)$157.8M0.0%+78.89%
41
New
1.7M$152.9M0.2%+1.78%
50
Decreased
1.6M(-13.3%)$140.4M0.0%+240.81%
0
Increased
1.5M(+447.6%)$131.2M0.0%+19.13%
49
Increased
1.5M(+66.8%)$130.8M0.0%+78.36%
44
Increased
1.1M(+11.6%)$98.9M0.0%+106.32%
33
New
1M$90.1M0.2%+1.78%
49
Increased
991,693(+612.1%)$88M0.1%+10.28%
48
Increased
988,009(+24.6%)$87.7M0.2%+172.33%
44
Decreased
955,196(-45.3%)$84.8M0.0%+304.65%
0
Increased
843,071(+25.6%)$74.8M0.0%+133.13%
36

Showing 1-20 of 155

1 / 8
SYRESYRESPYRE THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used